6.56
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.56
Aprire:
$6.42
Volume 24 ore:
328.91K
Relative Volume:
0.76
Capitalizzazione di mercato:
$123.08M
Reddito:
$109.43M
Utile/perdita netta:
$5.13M
Rapporto P/E:
25.17
EPS:
0.2606
Flusso di cassa netto:
$18.91M
1 W Prestazione:
-5.75%
1M Prestazione:
-11.23%
6M Prestazione:
-62.73%
1 anno Prestazione:
-21.25%
Optimizerx Corp Stock (OPRX) Company Profile
Nome
Optimizerx Corp
Settore
Industria
Telefono
248-651-6558
Indirizzo
260 CHARLES STREET, WALTHAM, MI
Compare OPRX vs VEEV, TEM, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
OPRX
Optimizerx Corp
|
6.56 | 123.08M | 109.43M | 5.13M | 18.91M | 0.2606 |
|
VEEV
Veeva Systems Inc
|
173.98 | 28.42B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
TEM
Tempus Ai Inc
|
47.39 | 8.47B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
43.10 | 8.28B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
84.67 | 7.15B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
WAY
Waystar Holding Corp
|
23.74 | 4.55B | 1.10B | 112.09M | 283.19M | 0.6096 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2024-04-04 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-02-02 | Ripresa | B. Riley Securities | Buy |
| 2022-11-01 | Iniziato | Stifel | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Outperform |
| 2021-10-18 | Ripresa | B. Riley Securities | Buy |
| 2021-04-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-01-03 | Iniziato | William Blair | Outperform |
Mostra tutto
Optimizerx Corp Borsa (OPRX) Ultime notizie
Are Investors Undervaluing OptimizeRx (OPRX) Right Now? - qz.com
If You Invested $1,000 in Optimizerx Corp (OPRX) - Stock Titan
What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now? - MSN
OptimizeRx (OPRX) price target decreased by 40.41% to 14.79 - MSN
New Top-Rated Stocks to Buy for April 1st - Bitget
OPRX Should I Buy - Intellectia AI
OptimizeRx (OPRX) soars 5.9%: Is further upside left in the stock? - MSN
OptimizeRx (NASDAQ: OPRX) switches auditors from UHY LLP to Grant Thornton - Stock Titan
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Vanguard disaggregates holdings; OPRX parent reports 0 shares (OPRX) - Stock Titan
OPRX Technical Analysis & ETF Price Forecast - Intellectia AI
OptimizeRx (OPRX) Jumps 5.9%: Does the Stock Have More Room to Grow? - Bitget
Earnings call transcript: OptimizeRx Q4 2025 earnings beat forecasts, stock dips - Investing.com Australia
OPRX SEC FilingsOptimizerx Corp 10-K, 10-Q, 8-K Forms - Stock Titan
OptimizeRx (OPRX) Soars 5.9%: Is Further Upside Left in the Stock? - finance.yahoo.com
Best Value Stocks to Buy for March 24th - sharewise.com
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates - MSN
Strength seen in OptimizeRx (OPRX): Can its 7.5% jump turn into more strength? - MSN
Guidance Update: Can OptimizeRx Corporation sustain earnings growthEntry Point & Fast Entry Momentum Alerts - baoquankhu1.vn
OPRX Technical Analysis & Stock Price Forecast - Intellectia AI
How The OptimizeRx (OPRX) Narrative Is Shifting As Guidance Resets And Valuation Expectations Reprice - Yahoo Finance
OptimizeRx Corp. (NASDAQ:OPRX) Short Interest Down 16.4% in February - MarketBeat
Is OptimizeRx (OPRX) Stock Undervalued Right Now? - Yahoo Finance
Best Value Stocks to Buy for March 16th - The Globe and Mail
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? - MSN
OptimizeRx Corp. (OPRX) Q4 earnings and revenues beat estimates - MSN
OptimizeRx (OPRX) outlines AI-driven pharma marketing strategy and key risks - Stock Titan
Should you sell your OptimizeRx stock? - Cantech Letter
OptimizeRx Corporation Common Stock OPRX ) Stock Price Today & Analysis - Gotrade
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2025 Earnings Call Transcript - Insider Monkey
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
OptimizeRx (OPRX) Q4 Profitability Turn Challenges Skeptical Earnings Narratives - simplywall.st
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $20.00 by Analysts at Lake Street Capital - MarketBeat
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $18.00 by Analysts at Roth Mkm - MarketBeat
OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty - Bitget
Assessing OptimizeRx: Insights From 4 Financial Analysts - Benzinga
B. Riley Financial Reaffirms Buy Rating for OptimizeRx (NASDAQ:OPRX) - MarketBeat
OptimizeRx (OPRX) Target Price Lowered by Stephens & Co. | OPRX Stock News - GuruFocus
Stephens Cuts OptimizeRx (NASDAQ:OPRX) Price Target to $10.00 - MarketBeat
OptimizeRx (NASDAQ:OPRX) Announces Quarterly Earnings Results - MarketBeat
Stephens cuts OptimizeRx stock price target on soft pharma budgets - Investing.com Nigeria
OptimizeRx Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript - AOL.com
Stephens cuts OptimizeRx stock price target on soft pharma budgets By Investing.com - Investing.com UK
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail
OptimizeRx Corp (OPRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
OptimizeRx Q4 Earnings Call Highlights - MarketBeat
Optimizerx Corp Azioni (OPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):